SpyGlass Pharma, Inc. (SGP) Stock

Healthcare · Biotechnology · Member of Other US Stocks

SpyGlass Pharma, Inc. (SGP) closed at USD 23.69 on 2026-10-14, a change of -10.3 % over the past year, with a market capitalization of USD 826.83M.

SpyGlass Pharma, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

SpyGlass Pharma, Inc. key figures

Previous close

USD 23.69 (2026-10-14)

1-year change

-10.3 %

Market cap

USD 826.83M

Enterprise value

USD 594.28M

P/E ratio (trailing)

-9.51

P/E ratio (forward)

-8.78

EPS (trailing)

-2.60

EPS (forward)

-2.81

PEG ratio

n/a

Price to book

3.56

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.86

Employees

76

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for SpyGlass Pharma, Inc. and compare it with other stocks.